ID

29137

Descripción

Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin; ODM derived from: https://clinicaltrials.gov/show/NCT00693771

Link

https://clinicaltrials.gov/show/NCT00693771

Palabras clave

Versiones (1)
  1. 28/2/18 28/2/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

28 de febrero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT00693771

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT00693771

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with type 2 diabetes mellitus inadequately controlled at least 3 months on premixed insulin with 1 or 2 oads
Descripción

Non-Insulin-Dependent Diabetes Mellitus Control Inadequate | Premixed insulin | Antidiabetics Oral Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0243148
UMLS CUI [1,3]
C0205412
UMLS CUI [2]
C2069057
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C1265611
7.5 ≤ hba1c ≤ 9.5%
Descripción

Glucohemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0202054
fpg ≥6.7 mmol/l
Descripción

Plasma fasting glucose measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0583513
history of diabetes mellitus ≤10 years
Descripción

Diabetes Mellitus Disease length

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0872146
premix insulin daily dosage ≤ 50 iu/day
Descripción

Premixed insulin Dosage IU/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2069057
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0439465
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes mellitus
Descripción

Diabetes Mellitus, Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
former treated on tzd
Descripción

Thiazolidinediones

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1257987
pregnancy / lactation
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
creatine ≥1.5 mg/dl
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
hepatic disease, jaundice,or alt/ast≥ 2.5 times of normal range
Descripción

Liver disease | Icterus | Alanine aminotransferase increased | Aspartate aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0022346
UMLS CUI [3]
C0151905
UMLS CUI [4]
C0151904
hormone therapy,
Descripción

Hormone Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279025
acute status of diabetes complications
Descripción

Status Complications of Diabetes Mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0449438
UMLS CUI [1,2]
C0342257
severe concomitant disease or complications with high risk of unexpected fatal events, like myocardial infarct, stroke, heart failure.
Descripción

Comorbidity Severe | Complication Severe | High risk Event Fatal Unexpected | Myocardial Infarction | Cerebrovascular accident | Heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C0332167
UMLS CUI [3,2]
C0441471
UMLS CUI [3,3]
C1302234
UMLS CUI [3,4]
C4055646
UMLS CUI [4]
C0027051
UMLS CUI [5]
C0038454
UMLS CUI [6]
C0018801
allergic to insulin glargine or any ingredient
Descripción

Hypersensitivity Insulin Glargine | Hypersensitivity Insulin Glargine Ingredient

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0907402
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0907402
UMLS CUI [2,3]
C1550600
participation in another clinical trial within 3 months
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Descripción

Study Subject Participation Status Aspect Additional

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1879746
UMLS CUI [1,3]
C1524062
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00693771

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Control Inadequate | Premixed insulin | Antidiabetics Oral Quantity
Item
patients with type 2 diabetes mellitus inadequately controlled at least 3 months on premixed insulin with 1 or 2 oads
boolean
C0011860 (UMLS CUI [1,1])
C0243148 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C2069057 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Glucohemoglobin measurement
Item
7.5 ≤ hba1c ≤ 9.5%
boolean
C0202054 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fpg ≥6.7 mmol/l
boolean
C0583513 (UMLS CUI [1])
Diabetes Mellitus Disease length
Item
history of diabetes mellitus ≤10 years
boolean
C0011849 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Premixed insulin Dosage IU/day
Item
premix insulin daily dosage ≤ 50 iu/day
boolean
C2069057 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0439465 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Thiazolidinediones
Item
former treated on tzd
boolean
C1257987 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy / lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Creatinine measurement, serum
Item
creatine ≥1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Liver disease | Icterus | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
hepatic disease, jaundice,or alt/ast≥ 2.5 times of normal range
boolean
C0023895 (UMLS CUI [1])
C0022346 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0151904 (UMLS CUI [4])
Hormone Therapy
Item
hormone therapy,
boolean
C0279025 (UMLS CUI [1])
Status Complications of Diabetes Mellitus
Item
acute status of diabetes complications
boolean
C0449438 (UMLS CUI [1,1])
C0342257 (UMLS CUI [1,2])
Comorbidity Severe | Complication Severe | High risk Event Fatal Unexpected | Myocardial Infarction | Cerebrovascular accident | Heart failure
Item
severe concomitant disease or complications with high risk of unexpected fatal events, like myocardial infarct, stroke, heart failure.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332167 (UMLS CUI [3,1])
C0441471 (UMLS CUI [3,2])
C1302234 (UMLS CUI [3,3])
C4055646 (UMLS CUI [3,4])
C0027051 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
C0018801 (UMLS CUI [6])
Hypersensitivity Insulin Glargine | Hypersensitivity Insulin Glargine Ingredient
Item
allergic to insulin glargine or any ingredient
boolean
C0020517 (UMLS CUI [1,1])
C0907402 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0907402 (UMLS CUI [2,2])
C1550600 (UMLS CUI [2,3])
Study Subject Participation Status
Item
participation in another clinical trial within 3 months
boolean
C2348568 (UMLS CUI [1])
Study Subject Participation Status Aspect Additional
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1,1])
C1879746 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial